<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
<channel>
<title><![CDATA[Insiderkauf.de (NTLA)]]></title>
<description><![CDATA[Alle Insidertrades, laufend aktualisiert - Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung!]]></description>
<link>https://beta.insiderkauf.de</link>
<image><url>https://beta.insiderkauf.de/android-chrome-512x512.png</url><title><![CDATA[Insiderkauf.de (NTLA)]]></title><link>https://beta.insiderkauf.de</link></image>
<generator>insider-trades-vanilla</generator>
<lastBuildDate>Mon, 10 Aug 2026 00:29:04 +0000</lastBuildDate>
<atom:link href="https://beta.insiderkauf.de/api/insidertrades/transactions/rss" rel="self" type="application/rss+xml"/>
<copyright><![CDATA[© 2026 Insiderkauf.de - Use of this feed is limited to personal, non-commercial use!]]></copyright>
<language><![CDATA[de]]></language>
<category><![CDATA[Aktien]]></category>
<category><![CDATA[Insider]]></category>
<category><![CDATA[Wirtschaft]]></category>
<category><![CDATA[Finanzen]]></category>
<ttl>60</ttl>
<pubDate>Mon, 10 Aug 2026 00:29:04 +0000</pubDate>
<item>
<title><![CDATA[EVP, Chief Financial Officer verkauft Aktien von Intellia Therapeutics]]></title>
<description><![CDATA[Insider: Dulac, Edward J III. <br/>Datum der Transaktion: 2026-07-22]]></description>
<link>https://beta.insiderkauf.de/company/NTLA-Intellia_Therapeutics?pk_campaign=rss</link>
<guid isPermaLink="false">58c27de4dd4ed616</guid>
<pubDate>Fri, 24 Jul 2026 22:26:12 +0000</pubDate>
<category><![CDATA[NTLA]]></category>
<category><![CDATA[Aktien]]></category>
<category><![CDATA[Insider]]></category>
<category><![CDATA[Wirtschaft]]></category>
<category><![CDATA[Finanzen]]></category>
<enclosure url="https://beta.insiderkauf.de/sale.png" length="17782" type="image/png"/>
</item>
<item>
<title><![CDATA[VP, Chief Accounting Officer verkauft Aktien von Intellia Therapeutics]]></title>
<description><![CDATA[Insider: Dube, Michael P. <br/>Datum der Transaktion: 2026-07-01]]></description>
<link>https://beta.insiderkauf.de/company/NTLA-Intellia_Therapeutics?pk_campaign=rss</link>
<guid isPermaLink="false">2f4337e2b020994e</guid>
<pubDate>Mon, 06 Jul 2026 22:02:06 +0000</pubDate>
<category><![CDATA[NTLA]]></category>
<category><![CDATA[Aktien]]></category>
<category><![CDATA[Insider]]></category>
<category><![CDATA[Wirtschaft]]></category>
<category><![CDATA[Finanzen]]></category>
<enclosure url="https://beta.insiderkauf.de/sale.png" length="17782" type="image/png"/>
</item>
<item>
<title><![CDATA[EVP, Chief Financial Officer verkauft Aktien von Intellia Therapeutics]]></title>
<description><![CDATA[Insider: Dulac, Edward J III. <br/>Datum der Transaktion: 2026-07-02]]></description>
<link>https://beta.insiderkauf.de/company/NTLA-Intellia_Therapeutics?pk_campaign=rss</link>
<guid isPermaLink="false">c20f6f573ad2ee6a</guid>
<pubDate>Mon, 06 Jul 2026 22:01:06 +0000</pubDate>
<category><![CDATA[NTLA]]></category>
<category><![CDATA[Aktien]]></category>
<category><![CDATA[Insider]]></category>
<category><![CDATA[Wirtschaft]]></category>
<category><![CDATA[Finanzen]]></category>
<enclosure url="https://beta.insiderkauf.de/sale.png" length="17782" type="image/png"/>
</item>
</channel>
</rss>